Whitepaper
Antibody-based therapeutic modalities in oncology
With over 200 different types of cancer, management relies on a variety of techniques such as chemotherapy, radiotherapy, and surgery. These types of therapies can be associated with severe side effects, and finding safer and more effective treatments is a priority in cancer therapeutics research. One approach that has shown huge potential is monoclonal antibody-based cancer therapeutics.
In this white paper we explore this exciting area of anti-cancer research, covering mechanism of action, development, and challenges in monoclonal antibody-based therapeutics, including antibody-drug conjugates and multispecific antibodies.
For research use only. Not for use in diagnostic procedures.
To view the full content please answer a few questions
Download Resource
Antibody-based therapeutic modalities in oncology